Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas: protocol for an open-label, non-randomised, Phase 2 study
Pre-publication versions of this article are available by contacting email@example.com.
|30 Nov 2018||Submitted||Original manuscript|
|15 Mar 2019||Reviewed||Reviewer Report - Scott Okuno|
|24 Mar 2019||Reviewed||Reviewer Report - Sandro Pasquali|
|23 May 2019||Author responded||Author comments - Hitomi Hara|
|Resubmission - Version 2|
|23 May 2019||Submitted||Manuscript version 2|
|2 Jun 2019||Reviewed||Reviewer Report - Sandro Pasquali|
|9 Jun 2019||Reviewed||Reviewer Report - Scott Okuno|
|14 Jun 2019||Author responded||Author comments - Hitomi Hara|
|Resubmission - Version 3|
|14 Jun 2019||Submitted||Manuscript version 3|
|3 Jul 2019||Reviewed||Reviewer Report - Sandro Pasquali|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|11 Jul 2019||Editorially accepted|
|23 Jul 2019||Article published||10.1186/s12885-019-5923-7|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.